GS
Gayatriben Shah
About Gayatriben Shah
Data last updated:
Gayatriben Shah is a Director at Advanov Pharma Private Limited (since 2023) and Director at Jewal Pharmaceutical Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹22.69 Cr; the largest is Advanov Pharma Private Limited at ₹22.68 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Feb 2023 | 2017 | ₹22.68 Cr (FY 2024) | Active | |
| Director | 15 Dec 2021 | 2021 | ₹32,000 (FY 2025) | Active |
Board colleagues of Gayatriben Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hemalkumar Rashmikant Shah | 08110574 | Advanov Pharma Private Limited , Jewal Pharmaceutical Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gayatriben Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gayatriben Shah
Gayatriben Shah currently holds 2 directorships: Advanov Pharma Private Limited (Director, since 06 Feb 2023, revenue ₹22.68 Cr (FY 2024)); Jewal Pharmaceutical Private Limited (Director, since 15 Dec 2021, revenue ₹32,000 (FY 2025)).
Gayatriben Shah was first appointed on 15 Dec 2021 as Director at Jewal Pharmaceutical Private Limited. The most recent appointment on record is 06 Feb 2023 at Advanov Pharma Private Limited.
The 2 current companies of Gayatriben Shah that report revenue have a combined latest revenue of ₹22.69 Cr: Advanov Pharma Private Limited ₹22.68 Cr (FY 2024); Jewal Pharmaceutical Private Limited ₹32,000 (FY 2025).
The current boards of Gayatriben Shah's companies include Hemalkumar Rashmikant Shah (Advanov Pharma Private Limited).